Búsqueda | Biblioteca Virtual en Salud

1.

Comparison of real-world treatment patterns among patients with psoriasis prescribed ixekizumab or secukinumab.

Blauvelt, Andrew; Shi, Nianwen; Burge, Russel; Malatestinic, William N; Lin, Chen-Yen; Lew, Carolyn R; Zimmerman, Nicole M; Goldblum, Orin M; Zhu, Baojin; Murage, Mwangi J.

J Am Acad Dermatol ; 82(4): 927-935, 2020 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-31712178

2.

Cost Per Additional Responder Associated With Ixekizumab and Etanercept in the Treatment of Moderate-to-Severe Psoriasis.

Feldman, Steven R; Foster, Shonda A; Zhu, Baojin; Burge, Russel; Al Sawah, Sarah; Goldblum, Orin M.

J Drugs Dermatol ; 16(12): 1246-1252, 2017 12 01.

Artículo en Inglés | MEDLINE | ID: mdl-29240860

3.

The current treatment landscape in adult atopic dermatitis in the United States: results from a cross-sectional real-world study.

Boytsov, Natalie N; Gorritz, Magdaliz; Wang, Xin; Malatestinic, William N; Wade, Rolin L; Goldblum, Orin M.

J Dermatolog Treat ; 33(3): 1707-1717, 2022 May.

Artículo en Inglés | MEDLINE | ID: mdl-33752555

4.

Inadequate response and treatment patterns in adults diagnosed with atopic dermatitis and treated with topical therapy.

Gorritz, Magdaliz; Boytsov, Natalie N; Goldblum, Orin M; Malatestinic, William N; Wang, Xin; Wade, Rolin L.

J Dermatolog Treat ; 33(5): 2510-2517, 2022 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-34612129

5.

US health care utilization and costs in adult patients with atopic dermatitis by disease severity.

Wang, Xin; Boytsov, Natalie N; Gorritz, Magdaliz; Malatestinic, William N; Goldblum, Orin M; Wade, Rolin L.

J Manag Care Spec Pharm ; 28(1): 69-77, 2022 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-34949118

6.

Assessment of the benefit of achieving complete versus almost complete skin clearance in psoriasis: a patient's perspective.

Korman, Neil J; Malatestinic, William; Goldblum, Orin M; Murage, Mwangi J; Renda, Lisa; Lin, Chen-Yen; Lucas, James; Middleton, Chloe; Lobosco, Steven.

J Dermatolog Treat ; 33(2): 733-739, 2022 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-32432957

7.

Disease response and patient-reported outcomes among initiators of ixekizumab.

Shahriari, Mona; Harrison, Ryan W; Burge, Russel; Lin, Chen-Yen; Malatestinic, William N; Goldblum, Orin M; McLean, Robert R; Crabtree, Margaux M; O'Brien, Jacqueline; Grace, Elsie L; Murage, Mwangi J.

J Dermatolog Treat ; 33(3): 1538-1546, 2022 May.

Artículo en Inglés | MEDLINE | ID: mdl-33267635

8.

Understanding characteristics of patients newly initiating ixekizumab: findings from the Corrona Psoriasis Registry.

Wu, Jashin J; Harrison, Ryan W; Zhu, Baojin; Goldblum, Orin M; Malatestinic, William N; Burge, Russel; Murage, Mwangi J.

J Comp Eff Res ; 10(2): 157-167, 2021 02.

Artículo en Inglés | MEDLINE | ID: mdl-33355477

9.

A Qualitative Analysis of Provider Notes of Atopic Dermatitis-Related Visits Using Natural Language Processing Methods.

Pierce, Evangeline J; Boytsov, Natalie N; Vasey, Joe J; Sudaria, Theresa C; Liu, Xiong; Lavelle, Kevin W; Bogdanov, Alina N; Goldblum, Orin M.

Dermatol Ther (Heidelb) ; 11(4): 1305-1318, 2021 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-34056694

10.

Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis.

Menter, Alan; Gordon, Kenneth B; Leonardi, Craig L; Gu, Yihua; Goldblum, Orin M.

J Am Acad Dermatol ; 63(3): 448-56, 2010 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-20605254

11.

Factors affecting sleep quality in patients with psoriasis.

Gowda, Smitha; Goldblum, Orin M; McCall, W Vaughn; Feldman, Steven R.

J Am Acad Dermatol ; 63(1): 114-23, 2010 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-19944485

12.

Comparison of Real-World Treatment Patterns Among Psoriasis Patients Treated with Ixekizumab or Adalimumab.

Blauvelt, Andrew; Shi, Nianwen; Burge, Russel; Malatestinic, William N; Lin, Chen-Yen; Lew, Carolyn R; Zimmerman, Nicole M; Goldblum, Orin M; Zhu, Baojin; Murage, Mwangi J.

Patient Prefer Adherence ; 14: 517-527, 2020.

Artículo en Inglés | MEDLINE | ID: mdl-32210539

13.

Comparison of Health Care Costs Among Patients with Psoriasis Initiating Ixekizumab, Secukinumab, or Adalimumab.

Blauvelt, Andrew; Shi, Nianwen; Zhu, Baojin; Burge, Russel; Malatestinic, William N; Lin, Chen-Yen; Lew, Carolyn R; Zimmerman, Nicole M; Goldblum, Orin M; Murage, Mwangi J.

J Manag Care Spec Pharm ; 25(12): 1366-1376, 2019 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-31778621

14.

Healthcare costs in psoriasis and psoriasis sub-groups over time following psoriasis diagnosis.

Al Sawah, Sarah; Foster, Shonda A; Goldblum, Orin M; Malatestinic, William N; Zhu, Baojin; Shi, Nianwen; Song, Xue; Feldman, Steven R.

J Med Econ ; 20(9): 982-990, 2017 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-28635342

15.

Practical applications of hand-held computers in dermatology.

Goldblum, Orin M.

Semin Cutan Med Surg ; 21(3): 190-201, 2002 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-12322992

16.

Immunotherapy and warts: a point of view.

Goihman-Yahr, Mauricio; Goldblum, Orin M.

Clin Dermatol ; 26(2): 223-5, 2008.

Artículo en Inglés | MEDLINE | ID: mdl-18472063

17.

Academic medical centers and conflicts of interest.

Goldblum, Orin M; Franzblau, Michael J.

JAMA ; 295(24): 2845-6; author reply 2848-9, 2006 Jun 28.

Artículo en Inglés | MEDLINE | ID: mdl-16804142

18.

Compounding of topical cidofovir.

Goldblum, Orin M; Zabawski, Edward J.

Arch Dermatol ; 138(2): 267, 2002 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-11843654

19.

Lichen planus.

Goldblum, Orin M.

Skinmed ; 1(1): 52-3, 2002.

Artículo en Inglés | MEDLINE | ID: mdl-14673238

20.

Psoriasis.

Goldblum, Orin M.

Skinmed ; 1(2): 132-4, 2002.

Artículo en Inglés | MEDLINE | ID: mdl-14673339

Biblioteca Virtual en Salud

Hipertensión

Su selección (0)

Formato de exportación:

Exportar:

Comparison of real-world treatment patterns among patients with psoriasis prescribed ixekizumab or secukinumab.

Cost Per Additional Responder Associated With Ixekizumab and Etanercept in the Treatment of Moderate-to-Severe Psoriasis.

The current treatment landscape in adult atopic dermatitis in the United States: results from a cross-sectional real-world study.

Inadequate response and treatment patterns in adults diagnosed with atopic dermatitis and treated with topical therapy.

US health care utilization and costs in adult patients with atopic dermatitis by disease severity.

Assessment of the benefit of achieving complete versus almost complete skin clearance in psoriasis: a patient's perspective.

Disease response and patient-reported outcomes among initiators of ixekizumab.

Understanding characteristics of patients newly initiating ixekizumab: findings from the Corrona Psoriasis Registry.

A Qualitative Analysis of Provider Notes of Atopic Dermatitis-Related Visits Using Natural Language Processing Methods.

Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis.

Factors affecting sleep quality in patients with psoriasis.

Comparison of Real-World Treatment Patterns Among Psoriasis Patients Treated with Ixekizumab or Adalimumab.

Comparison of Health Care Costs Among Patients with Psoriasis Initiating Ixekizumab, Secukinumab, or Adalimumab.

Healthcare costs in psoriasis and psoriasis sub-groups over time following psoriasis diagnosis.

Practical applications of hand-held computers in dermatology.

Immunotherapy and warts: a point of view.

Academic medical centers and conflicts of interest.

Compounding of topical cidofovir.

Lichen planus.

Psoriasis.